Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally. The company offers COVID-19 solutions, such as antigen combo rapid and antigen test range; HUMAN RAPID TESTs, including women's health, infectious disease, drugs of abuse, tumor markers, cardiac markers, home use, and other rapid tests; LF readers; and veterinary products comprising veterinary chemiluminescence and fluorescence immunoassay, veterinary LF readers, dry biochemistry, and immunoblotting, as well as canine, feline, porcine, and bovine test ranges. It also provides fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, blood glucose monitoring systems; Hb hemoglobin test meters, cholesterol meters, and VTM products; PCR kits; immunoblotting test kits; chemiluminescence immunoassay analyzers and tests; and blood grouping reagents. Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is headquartered in Hangzhou, China.
